Immune correlates of HIV exposure without infection in foreskins of men from Rakai, Uganda

Mucosal Immunology

Volumn 7, Issue 3, 2014, Pages 634-644

  Prodger, J L ^a   Hirbod, T ^b   Kigozi, G ^c   Nalugoda, F ^c   Reynolds, S J ^c,d,e   Galiwango, R ^c   Shahabi, K ^a   Serwadda, D ^c,f   Wawer, M J ^c,g   Gray, R H ^c,g   Kaul, R ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b KAROLINSKA INSTITUTE   (Sweden)

^c RAKAI HEALTH SCIENCES PROGRAM   (Uganda)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MAKERERE UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Uganda)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; CD3 ANTIGEN; IMMUNOGLOBULIN A; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DENSITY; CELLULAR IMMUNITY; CIRCUMCISION; CONTROLLED STUDY; CYTOKINE RESPONSE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INNATE IMMUNITY; LONG TERM EXPOSURE; MALE; PREPUCE; PRIORITY JOURNAL; SERODIAGNOSIS; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; UGANDA; DISEASE PREDISPOSITION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; MIDDLE AGED; PHENOTYPE; SEXUAL BEHAVIOR; VIROLOGY; YOUNG ADULT;

ADULT; ANTIBODIES, NEUTRALIZING; CYTOKINES; DISEASE SUSCEPTIBILITY; FEMALE; FORESKIN; HIV ANTIBODIES; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN A; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; PHENOTYPE; SEXUAL BEHAVIOR; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTE SUBSETS; UGANDA; YOUNG ADULT;

EID: 84897464454     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2013.83     Document Type: Article

References (49)

1. Hladik, F. & McElrath,M.J. Setting the stage: host invasion by HIV. Nat. Rev. Immunol. 8, 447-457 (2008).
2. Levinson, P. et al. HIV-neutralizing activity of cationic polypeptides in cervicovaginal secretions of women in HIV-serodiscordant relationships. PLoS ONE 7, e31996 (2012).
3. Levinson, P. et al. Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition. AIDS 23, 309-317 (2009).
4. Quinones-Mateu, M.E. et al. Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS 17, F39-F48 (2003).
5. Zapata,W. et al. Increased levels of human beta-defensins mRNA in sexually HIV-1 exposed but uninfected individuals. Curr. HIV Res. 6, 531-538 (2008).
6. Lajoie, J. et al. A distinct cytokine and chemokine profile at the genital mucosa is associated with HIV-1 protection among HIV-exposed seronegative commercial sex workers. Mucosal Immunol. 5, 277-287 (2012).
7. Burgener, A. et al. Salivary basic proline-rich proteins are elevated in HIVexposed seronegative men who have sex with men. AIDS 26, 1857-1867 (2012).
8. Iqbal, S.M. et al. Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition. AIDS 23, 1669-1677 (2009).
9. Hirbod, T. et al. Upregulation of interferon-alpha and RANTES in the cervix of HIV-1-seronegative women with high-risk behavior. J. Acquir. Immune Defic. Syndr. 43, 137-143 (2006).
10. Hirbod, T. et al. HIV-1 neutralizing activity is correlated with increased levels of chemokines in saliva of HIV-1-exposed uninfected individuals. Curr. HIV Res. 6, 28-33 (2008).
11. Iqbal, S.M. et al. Elevated T cell counts and RANTES expression in the genital mucosa of HIV-1-resistant Kenyan commercial sex workers. J. Infect. Dis. 192, 728-738 (2005).
12. Hasselrot, K. et al. Oral HIV-exposure elicits mucosal HIV-neutralizing antibodies in uninfected men who have sex with men. AIDS 23, 329-333 (2009).
13. Choi, R.Y. et al. Cervicovaginal HIV-1 neutralizing IgA detected amongHIV-1-exposed seronegative female partners in HIV-1-discordant kenyan couples. AIDS 26, 2155-2163 (2012).
14. Hirbod, T. et al. HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers. AIDS 22, 727-735 (2008).
15. Kaul, R. et al. Genital levels of soluble immune factors with anti-HIV activity may correlate with increased HIV susceptibility. AIDS 22, 2049-2051 (2008).
16. Zhou, Z. et al. HIV-1 efficient entry in inner foreskin is mediated by elevated CCL5/RANTES that recruits T cells and fuels conjugate formation with Langerhans cells. PLoS Pathog. 7, e1002100 (2011).
17. Card,Catherine M. et al. Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4+CD25+ FOXP3+ regulatory T cells. J. Infect. Dis. 199, 1318-1322 (2009).
18. Legrand, F.A. et al. Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal. PLoS ONE 1, e102 (2006).
19. Bégaud, E. et al. Reduced CD4 Tcell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans. Retrovirology 3, 35 (2006).
20. Koning, F.A. et al. Low-level CD4+ Tcell activation is associated with low susceptibility to HIV-1 infection. J. Immunol. 175, 6117-6122 (2005).
21. Camara, M. et al. Low-level CD4+ T cell activation in HIV-exposed seronegative subjects: influence of gender and condom use. J. Infect. Dis. 201, 835-842 (2010).
22. Chege, D. et al. Blunted IL17/IL22 and pro-inflammatory cytokine responses in the genital tract and blood of HIV-exposed, seronegative female sex workers in Kenya. PLoS ONE 7, e43670 (2012).
23. McLaren, P.J. et al. HIV-exposed seronegative commercial sex workers show a quiescent phenotype in the CD4+ T cell compartment and reduced expression of HIV-dependent host factors. J. Infect. Dis. 202 (Suppl 3), S339-S344 (2010).
24. Auvert, B. et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV Infection risk: the ANRS 1265 trial. PLoS Med. 2, e298 (2005).
25. Bailey, R. et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369, 643-656 (2007).
26. Gray, R.H. et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369, 657-666 (2007).
27. Prodger, J.L. et al. Foreskin T-cell subsets differ substantially from blood with respect to HIV co-receptor expression, inflammatory profile, and memory status. Mucosal Immunol. 5, 121-128 (2012).
28. Gray, R.H. et al. Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. AIDS 14, 2371-2381 (2000).
29. Prodger, J.L. et al. Impact of asymptomatic Herpes simplex virus-2 infection on T cell phenotype and function in the foreskin. AIDS 26, 1319-1322 (2012).
30. Beyrer, C. et al. Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group. J. Infect. Dis. 179, 59-67 (1999).
31. Broliden, K. et al. Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers. Immunol. Lett. 79, 29-36 (2001).
32. Devito, C. et al. Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate. AIDS 14, 1917-1920 (2000).
33. Kaul, R. et al. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. AIDS 13, 23-29 (1999).
34. Lo Caputo, S. et al. Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men. AIDS 17, 531-539 (2003).
35. Hirbod, T., Broliden, K. & Kaul, R. Genital immunoglobulin A and HIV-1 protection: virusneutralization versus specificity. AIDS22, 2401-2402 (2008).
36. Fiore, J.R. et al. Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding. New Microbiol. 23, 85-92 (2000).
37. Horton, R.E. et al. Cervical HIV-specific IgA in a population of commercial sex workers correlates with repeated exposure but not resistance to HIV. AIDS Res. Hum. Retroviruses 25, 83-92 (2009).
38. Soderlund, J. et al. Plasma and mucosal fluid from HIV type 1-infected patients but not from HIV type 1-exposed uninfected subjects prevent HIV type 1-exposed DC from infecting other target cells. AIDS Res. Hum. Retroviruses 23, 101-106 (2007).
39. Cicala, C. et al. The integrin a4b7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. Proc. Natl Acad Sci 106, 20877-20882 (2009).
40. Li, Q. et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature 458, 1034-1038 (2009).
41. Gosselin, A. et al. Peripheral blood CCR4+CCR6+ and CXCR3+ CCR6+CD4+ Tcells are highly permissive to HIV-1 infection. J. Immunol. 184, 1604-1616 (2010).
42. Monteiro, P. et al. Memory CCR6+CD4+ T cells are preferential targets for productive HIV type 1 infection regardless of their expression of integrin beta7. J. Immunol. 186, 4618-4630 (2011).
43. Zhang, Z.Q. Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection. Proc. Natl. Acad Sci 101, 5640-5645 (2004).
44. Jaspan, H.B. et al. Immune activation in the female genital tract during HIV infection predicts mucosal CD4 depletion and HIV shedding. J. Infect. Dis. 204, 1550-1556 (2011).
45. Fahrbach, K.M., Barry, S.M., Anderson, M.R. & Hope, T.J. Enhanced cellular responses and environmental sampling within inner foreskin explants: implications for the foreskin's role in HIV transmission. Mucosal Immunol 3, 410-418 (2010).
46. Ganor, Y. et al.Within 1 h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages Langerhans-T cell conjugates. Mucosal Immunol. 3, 506-522 (2010).
47. Kim, C.J. et al. A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis. Mucosal Immunol. 5, 670-680 (2012).
48. Gamiel, J.L. et al. Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda. Clin. Vaccine Immunol. 15, 888-890 (2008).
49. Kaul, R. et al. New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers. Immunol. Lett. 79, 3-13 (2001).